These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Clinical significance of IgG anti-Sm antibodies in patients with systemic lupus erythematosus. Yasuma M; Takasaki Y; Matsumoto K; Kodama A; Hashimoto H; Hirose S J Rheumatol; 1990 Apr; 17(4):469-75. PubMed ID: 2348425 [TBL] [Abstract][Full Text] [Related]
24. [The clinical significance of soluble nuclear antigen specific antibodies (author's transl)]. Peltier AP; Gaudreau A; Amor B; Kahn MF; Ryckewaert A; Sany J; Haim T Nouv Presse Med; 1978 May; 7(21):1813-8. PubMed ID: 307737 [TBL] [Abstract][Full Text] [Related]
25. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon]. Uchida K; Kondo H; Kashiwazaki S Ryumachi; 1984 Aug; 24(4):241-9. PubMed ID: 6334895 [No Abstract] [Full Text] [Related]
26. Late onset systemic lupus erythematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis. Adu D; Williams DG; Taube D; Vilches AR; Turner DR; Cameron JS; Ogg CS Q J Med; 1983; 52(208):471-87. PubMed ID: 6606818 [TBL] [Abstract][Full Text] [Related]
27. Association of neutrophil extracellular trap levels with Raynaud's phenomenon, glomerulonephritis and disease index score in SLE patients from Brazil. Delabio Auer E; Bumiller-Bini Hoch V; Borges da Silva E; Ricci Zonta Y; Alarcão Dias-Melicio L; Larocca Skare T; F Picceli V; Messias-Reason IJ; Boldt ABW Immunobiology; 2024 May; 229(3):152803. PubMed ID: 38640572 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of Sm antibody in family members of Sm positive patients with systemic lupus erythematosus. Doll NJ; Wilson MR; Salvaggio JE J Rheumatol; 1980; 7(3):334-8. PubMed ID: 6967521 [TBL] [Abstract][Full Text] [Related]
34. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 European lupus patients. European Consensus Study Group for Disease Activity in SLE. Vitali C; Bencivelli W; Isenberg DA; Smolen JS; Snaith ML; Sciuto M; d'Ascanio A; Bombardieri S Clin Exp Rheumatol; 1992; 10(5):527-39. PubMed ID: 1458709 [TBL] [Abstract][Full Text] [Related]
35. [Disseminated lupus erythematosus without antinuclear antibodies or other autoantibodies]. Duc J; Perroulaz G; Golaz J; Campiche M; Pécoud A Schweiz Med Wochenschr; 1987 Feb; 117(6):205-8. PubMed ID: 3494306 [TBL] [Abstract][Full Text] [Related]
36. What is the clinical significance of anti-Sm antibodies in systemic lupus erythematosus? A comparison with anti-dsDNA antibodies and C3. Flechsig A; Rose T; Barkhudarova F; Strauss R; Klotsche J; Dähnrich C; Schlumberger W; Enghard P; Burmester GR; Hiepe F; Biesen R Clin Exp Rheumatol; 2017; 35(4):598-606. PubMed ID: 28281463 [TBL] [Abstract][Full Text] [Related]
37. The delayed appearance of an antinuclear factor and the diagnosis of systemic lupus erythematosus in glomerulonephritis. Cairns SA; Acheson EJ; Corbett CL; Dosa S; Mallick NP; Lawler W; Williams G Postgrad Med J; 1979 Oct; 55(648):723-7. PubMed ID: 317153 [TBL] [Abstract][Full Text] [Related]
38. Three siblings with systemic lupus erythematosus. Shu E; Ichiki Y; Moriya C; Iwata H; Kitajima Y; Seishima M J Dermatol; 2012 Feb; 39(2):164-7. PubMed ID: 22132698 [TBL] [Abstract][Full Text] [Related]
39. Anticentromere antibody in patients without CREST and scleroderma: association with active digital vasculitis, rheumatic and connective tissue disease. Goldman JA Ann Rheum Dis; 1989 Sep; 48(9):771-5. PubMed ID: 2802800 [TBL] [Abstract][Full Text] [Related]